Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.European Commission (EC) has unveiled a new strategy focused on advancing the development, manufacturing and deployment of Covid-19 vaccines.
EC has committed to help speed-up the development and availability of safe and effective vaccines in a timeframe of 12 to 18 months, and if possible earlier.
This would require a simultaneous focus on clinical trials and scale-up of manufacturing capacity. The strategy calls for a joint approach across the European Union (EU).
One such joint initiative has already been launched in the form of Inclusive Vaccine Alliance (IVA) by France, Germany, Italy and the Netherlands.
Read more on pharmaceutical-technology.com